CoQ-10 was first identified in 1957. It is widely used in Japan where millions of Japanese patients receive CoQ-10 as part of their treatment for congestive heart failure.
- Scientific Names: Mitoquinone; Ubidecarenone; Ubiquinone
- Indications: Congestive heart failure, angina, diabetes, hypertension, breast cancer, increasing exercise tolerance, muscular dystrophy, chronic fatigue
- Synonym: None
- Class: Food supplement
- Half-life: N/A
- Clinically important, potentially hazardous interactions with:
None known
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
